Literature DB >> 21951015

Partially dominant mutant channel defect corresponding with intermediate LQT2 phenotype.

Yamini Krishnan1, Renjian Zheng, Christine Walsh, Yingying Tang, Thomas V McDonald.   

Abstract

BACKGROUND: The hereditary Long QT Syndrome is a common cardiac disorder where ventricular repolarization is delayed, abnormally prolonging the QTc interval on electrocardiograms. LQTS is linked to various genetic loci, including the KCNH2 (HERG) gene that encodes the α-subunit of the cardiac potassium channel that carries I(Kr). Here, we report and characterize a novel pathologic missense mutation, G816V HERG, in a patient with sudden cardiac death.
METHODS: Autopsy-derived tissue sample was used for DNA extraction and sequencing from an unexpected sudden death victim. The G816V HERG mutation was studied using heterologous expression in mammalian cell culture, whole cell patch clamp, confocal immunofluorescence, and immunochemical analyses.
RESULTS: The mutant G816V HERG channel has reduced protein expression and shows a trafficking defective phenotype that is incapable of carrying current when expressed at physiological temperatures. The mutant channel showed reduced cell surface localization compared to wild-type HERG (WT HERG) but the mutant and wild-type subunits are capable of interacting. Expression studies at reduced temperatures enabled partial rescue of the trafficking defect with appearance of potassium currents, albeit with reduced current density and altered voltage-dependent activation. Lastly, we examined a potential role for hypokalemia as a contributory factor to the patient's lethal arrhythmia by possible low-potassium-induced degradation of WT HERG and haplo-insufficiency of G816V HERG.
CONCLUSION: The G816V mutation in HERG causes a trafficking defect that acts in a partially dominant negative manner. This intermediate severity defect agrees with the mild clinical presentation in other family members harboring the same mutation. Possible hypokalemia in the proband induced WT HERG degradation combined with haplo-insufficiency may have further compromised repolarization reserve and contributed to the lethal arrhythmia. ©2011, The Authors. Journal compilation ©2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951015      PMCID: PMC3248989          DOI: 10.1111/j.1540-8159.2011.03222.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  36 in total

1.  Characterization of S818L mutation in HERG C-terminus in LQT2. Modification of activation-deactivation gating properties.

Authors:  T Nakajima; M Kurabayashi; Y Ohyama; Y Kaneko; T Furukawa; T Itoh; Y Taniguchi; T Tanaka; Y Nakamura; M Hiraoka; R Nagai
Journal:  FEBS Lett       Date:  2000-09-15       Impact factor: 4.124

2.  Cyclic AMP regulates the HERG K(+) channel by dual pathways.

Authors:  J Cui; Y Melman; E Palma; G I Fishman; T V McDonald
Journal:  Curr Biol       Date:  2000-06-01       Impact factor: 10.834

3.  Role of glycosylation in cell surface expression and stability of HERG potassium channels.

Authors:  Qiuming Gong; Corey L Anderson; Craig T January; Zhengfeng Zhou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

4.  Identification of a COOH-terminal segment involved in maturation and stability of human ether-a-go-go-related gene potassium channels.

Authors:  Armin Akhavan; Roxana Atanasiu; Alvin Shrier
Journal:  J Biol Chem       Date:  2003-07-28       Impact factor: 5.157

5.  Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects.

Authors:  Z Zhou; Q Gong; C T January
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

6.  The role of monoubiquitination in endocytic degradation of human ether-a-go-go-related gene (hERG) channels under low K+ conditions.

Authors:  Tao Sun; Jun Guo; Heidi Shallow; Tonghua Yang; Jianmin Xu; Wentao Li; Christian Hanson; James G Wu; Xian Li; Hamid Massaeli; Shetuan Zhang
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

7.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

8.  Defective human Ether-à-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus.

Authors:  Sabina Kupershmidt; Tao Yang; Siprachanh Chanthaphaychith; Zhiqing Wang; Jeffrey A Towbin; Dan M Roden
Journal:  J Biol Chem       Date:  2002-05-20       Impact factor: 5.157

Review 9.  Pharmacogenetic considerations in diseases of cardiac ion channels.

Authors:  Arun Anantharam; Steven M Markowitz; Geoffrey W Abbott
Journal:  J Pharmacol Exp Ther       Date:  2003-10-15       Impact factor: 4.030

10.  A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations.

Authors:  Susan P Etheridge; Steven J Compton; Martin Tristani-Firouzi; Jay W Mason
Journal:  J Am Coll Cardiol       Date:  2003-11-19       Impact factor: 24.094

View more
  2 in total

1.  Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome.

Authors:  Corey L Anderson; Catherine E Kuzmicki; Ryan R Childs; Caleb J Hintz; Brian P Delisle; Craig T January
Journal:  Nat Commun       Date:  2014-11-24       Impact factor: 14.919

2.  Molecular autopsy: using the discovery of a novel de novo pathogenic variant in the KCNH2 gene to inform healthcare of surviving family.

Authors:  Jingyun Dong; Nori Williams; Marina Cerrone; Christopher Borck; Dawei Wang; Bo Zhou; Lucy S Eng; Ekaterina Subbotina; Sung Yon Um; Ying Lin; Kevin Ruiter; Lisa Rojas; William A Coetzee; Barbara A Sampson; Yingying Tang
Journal:  Heliyon       Date:  2018-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.